List of companies in BioTrack Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases. | ||||||
NuProbe is a Cambridge, Massachusetts-based molecular diagnostics company focused on accelerating precision diagnostics. | ||||||
Qitan Technology is a Chengdu-based company founded in 2015 by Dan Xie, Jin Wang, Geng Hu, Geng Hu and Jingwei Bai. | ||||||
Brattea is a Shanghai-based company founded in 2013 by Mr. Hongguang Cao. | ||||||
BioNova Pharma is a Shanghai-based company founded in 2018 by Bryan Huang. | ||||||
Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases. | ||||||
Mobile Vision Network Technology is a Shanghai-based company founded in 2015. | ||||||
CytoLynx Therapeutics is a Shanghai-based company founded in 2021 by Laura Hong. | ||||||
Minghui Pharmaceutical is a Shanghai-based, late-stage biopharmaceutical company pioneering next-generation immuno-oncology therapies, including PD-1/VEGF bispecifics, IGF-1R inhibitors, and its lead B7-H3 ADC (MHB088C). In mid-2025, it secured USD 186 million licensing plus milestone and royalty payments from Qilu Pharma for Greater China rights. |
